EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The potential and risks of FLASH radiotherapy in pediatric patients

Jan Schuemann iD, Bethany Rothwell iD, Anthony Mascia iD, Yi Fan, Billy W Loo iD, Torunn Yock iD, Kevin X Liu, John Perentesis iD, Daphne A Haas-Kogan iD

Neuro-Oncology Pediatrics · 2026

DOI: 10.1093/neuped/wuaf014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuro-Oncology Pediatrics, 2026. Verfasst von Jan Schuemann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Massachusetts General Brigham, Boston, MA, United States. Die Arbeit nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, William M. Wood Foundation, NCI Specialized Programs of Research Excellence (SPOREs) in Human Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Irradiation at ultra-high dose rates, also termed as ‘FLASH’ radiotherapy, has generated great interest in radiation oncology due to its potential to preferentially spare healthy tissue without compromising tumor control. Over the past decade, studies on the potential benefits of FLASH radiotherapy (FLASH-RT) have grown rapidly, yet the underlying mechanisms of this differential effect remain poorly understood. Nonetheless, compelling preclinical data, particularly the preservation of cognitive function after whole-brain irradiation, suggest that FLASH-RT may significantly improve quality of life, especially for pediatric patients. Early preclinical (large animal) and adult clinical trials are underway, prompting consideration of how and when to translate this modality to pediatric populations. This review summarizes the current state of FLASH-RT, with a special focus on pediatric CNS applications. We discuss disease-specific opportunities and limitations, how biological and clinical differences between adults and children may influence the FLASH effect, and key factors that must be evaluated before safe and effective pediatric translation.

Schlagwörter

Stichwörter der Autor:innen

FLASHclinical translationpediatricsultra-high dose rate

Autor:innen und Institutionen

  • Department of Radiation Oncology, Massachusetts General Brigham, Boston, MA, United States.
  • Division of Oncology, Cancer and Blood Disease Institute, Cincinnati Children's Hospital, Cincinnati, OH, United States.
  • Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, United States.
  • Department of Radiation Oncology & Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, United States.
  • Department of Radiation Oncology, Dana Farber Cancer Institute, Boston Children's Hospital, Boston, MA, United States.

ORCID-Profile: Jan Schuemann, Bethany Rothwell, Anthony Mascia, Billy W Loo, Torunn Yock, John Perentesis, Daphne A Haas-Kogan

Förderung

  • National Institutes of Health
  • William M. Wood Foundation
  • NCI Specialized Programs of Research Excellence (SPOREs) in Human Cancer

Zitieren

APA

Schuemann, J., Rothwell, B., Mascia, A., Fan, Y., Loo, B. W., Yock, T., Liu, K. X., Perentesis, J., & Haas-Kogan, D. A. (2026). The potential and risks of FLASH radiotherapy in pediatric patients. Neuro-Oncology Pediatrics. https://doi.org/10.1093/neuped/wuaf014

Vancouver

Schuemann J, Rothwell B, Mascia A, Fan Y, Loo BW, Yock T, et al. The potential and risks of FLASH radiotherapy in pediatric patients. Neuro-Oncology Pediatrics. 2026. doi:10.1093/neuped/wuaf014

BibTeX
@article{Schuemann2026,
  author = {Schuemann, Jan and Rothwell, Bethany and Mascia, Anthony and Fan, Yi and Loo, Billy W and Yock, Torunn and Liu, Kevin X and Perentesis, John and Haas-Kogan, Daphne A},
  title = {The potential and risks of FLASH radiotherapy in pediatric patients},
  journal = {Neuro-Oncology Pediatrics},
  year = {2026},
  doi = {10.1093/neuped/wuaf014}
}
Kostenlos starten →